期刊
CANCER LETTERS
卷 292, 期 1, 页码 8-16出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2009.11.010
关键词
MicroRNA; Pancreatic cancer; Diagnosis and therapy
类别
资金
- National Institutes of Health [CA78590, CA111294, CA133774, CA131944]
MicroRNAs (miRNAs) are a group of small non-coding RNA molecules of 17-25 nucleotides (nt) in length, predicted to control the activity of about 30% of all protein-coding genes in mammals. Altered expressions of miRNAs are reported in various cancers and may associate with cancer pathogenesis, apoptosis, and cell growth, thereby functioning as either tumor suppressors or oncogenes. Recent reports showed that deregulation of miRNA contribute to tumor development and progression and hence, have diagnostic and prognostic value in several human malignancies. This review discusses the current status of miRNA in pancreatic cancer development, progression, diagnosis, and therapy. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据